Regulatory & Clinical Safety Disclosures: Compounded formulations of Semaglutide and Tirzepatide are customized medications prepared by licensed 503A compounding pharmacies to meet individual patient needs, but they are not FDA-approved or evaluated for safety and efficacy by the FDA
Injectable B12 is the primary management strategy for those with altered gastric acidity and/or Intrinsic Factor
Samita Garg, MD, associate professor of medicine at Cleveland Clinic Lerner College of Case Western Reserve University, and director of multidisciplinary gastroenterology endocrine GLP clinic in the department of gastroenterology, hepatology and nutrition at the Digestive Disease Institute, Cleveland Clinic Foundation, said the prevalence of overweight and obesity has been increasing among people with type 1 diabetes in recent years
Read Also: Doctor-Supervised GLP-1 Weight Loss Program in Gurgaon Focus on Protein to Protect Your Results One of the most effective strategies after stopping GLP-1 Medication is maintaining a high-protein diet
There was no difference in protein binding between the groups